XLO
Xilio Therapeutics, Inc.
NASDAQ · Healthcare · Biotechnology · US
$8.03
+3.35%Leverage
- Debt / equity
- 0.09x
- Net debt / equity
- -1.80x
- Debt / assets
- 0.04x
- Debt / EBITDA
- -0.31x
- Net debt / EBITDA
- 6.33x
Liquidity & coverage
- Current ratio
- 4.25x
- Quick ratio
- 4.25x
- Cash ratio
- 3.98x
- Interest coverage
- —
- EBITDA / interest
- —
- Working capital
- $111.3M
Cash & dividend
- FCF / debt
- -9.72x
- Cash flow / debt
- -9.61x
- Dividend per share
- —
- Dividend yield
- —
- Dividend growth 1y
- —
Leverage, liquidity, debt coverage and shareholder-distribution metrics · Data as of Jun 1, 2026